Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Thyroid Nodule 1Thyroid Neoplasms 1Sarcoma, Synovial 1Sarcoma 1Neurofibrosarcoma 1Malignant mesenchymal tumor 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Fibrosarcoma 1Chondrosarcoma, Extraskeletal Myxoid 1Carcinoma, Lobular 1COVID-19 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Surveys and Questionnaires 3BNT162 Vaccine 3Surgical Procedures, Operative 2sinovac COVID-19 vaccine 1Serologic Tests 1Prednisone 1Molecular Diagnostic Techniques 1Methylprednisolone 1Medical Marijuana 1Magnetic Resonance Spectroscopy 1Hydroxychloroquine 1High-Throughput Nucleotide Sequencing 1Glucocorticoids 1Drug Therapy 1Dexamethasone 1Data Collection 1CVnCoV COVID-19 vaccine 1COVID-19 Vaccines 1COVID-19 Serotherapy 1Azithromycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × COVID-19 × Molecular Diagnostic Techniques × Clear all
NCT04377802 2020-05-06

Safe Return to Regular Clinical Operation After COVID-19 Pandemic

King Fahad Specialist Hospital Dammam

Phase NA Unknown
400 enrolled

COVID-19

Data powered by HemOnc (CC BY 4.0) Colophon âš¡